(Q44384098)
Statements
Exenatide improves weight loss insulin sensitivity and β-cell function following administration to a type 2 diabetic HIV patient on antiretroviral therapy (English)
M P Hermans
P Selvais
M Buysschaert
X de la Tribonnière